Pasar al contenido principal

RECONSTRUCCION EVOLUTIVA DE PROTEINAS DE VIRUS QUE SON DIANA DE TERAPIAS MEDIANTE MODELOS INTEGRADOS DE SELECCION SOBRE SECUENCIA, ESTRUCTURA Y FUNCION DE PROTEINAS

PID2023-151032NB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VIGO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Molecular evolution and phylogeography of the Crimean–Congo hemorrhagic fever virus

  • Iglesias Rivas, Paula
  • González Vázquez, Luis Daniel
  • Arenas Busto, Miguel
The Crimean–Congo hemorrhagic fever virus (CCHFV) is a single-stranded, segmented RNA virus belonging to the Nairoviridae family, and it is rapidly expanding across Africa, Asia, and southern Europe, probably favored by climate change and livestock trade. Its fatality rate in humans reaches up to 40%, and there is currently no specific treatment or vaccine available. Therefore, the development of therapies against CCHFV is essential, and their design requires understanding of the molecular evolution and genetic distribution of the virus. Motivated by these concerns, we present a comprehensive review of the molecular evolution, genetic characterization, and phylogeography of CCHFV, and we discuss their potential implications for therapeutic design. Specifically, we describe the virus’s capacity to increase its genetic diversity through numerous mutations, recombination events, and genomic reassortments, which affect fundamental viral functions such as RNA binding, host–virus interactions, viral entry, and polymerase activity. We also assess the presence of temporal heterogeneous rates of evolution and molecular adaptation among CCHFV coding regions, where purifying selection is generally predominant but diversifying selection is observed in molecular regions associated with host adaptation and transmission. We emphasize the importance of understanding the complex molecular evolution of CCHFV for the rational design of therapies and highlight the need for efforts in surveillance, evolutionary prediction, and therapeutic development., Agencia Estatal de Investigación | Ref. PID2023-151032NB-C22, Xunta de Galicia | Ref. ED481A-2023/089
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Empirical substitution models of protein evolution: database, relationships, and modeling considerations

  • Iglesias Rivas, Paula
  • Del Amparo Temporao, Roberto
  • Cabaleiro Rojo, Javier A
  • Arenas Busto, Miguel
Substitution models of protein evolution describe the patterns of amino acid substitutions over evolutionary time and are fundamental for probabilistic methods of phylogenetic inference. At the protein level, a variety of substitution models are available, but only empirical substitution models are well established in phylogenetics due to their mathematical simplicity. Despite their importance, a database compiling the large number of currently available empirical substitution models of protein evolution is lacking, although such a resource could facilitate access, assessment, and subsequent implementation of these models into phylogenetic frameworks. Besides, little is known about formal comparisons between the current set of empirical substitution models. We present EModelDB, a database of empirical substitution models of protein evolution required for probabilistic protein phylogenetics that includes the corresponding exchangeability matrices, model classification, and model-specific biological information. The database is integrated into a graphical user interface, written in Python and SQL, that facilitates its usability. We also compared common empirical substitution models in terms of the distance between their relative rates of amino acid substitution and amino frequencies at equilibrium. We found that substitution models derived from proteins related in nature tend to cluster together, reflecting similar evolutionary patterns. Indeed, we evaluated the empirical substitution models in terms of the folding stability of the derived modeled proteins and found that they generally produce less stable proteins compared to real proteins, suggesting that substitution models with additional evolutionary constraints can be preferred for studying protein evolution accounting for folding stability., Agencia Estatal de Investigación | Ref. PID2023-151032NB-C22, Universidade de Vigo/CISUG, Ministerio de Universidades | Ref. REC-SALAS-22
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Forecasting protein evolution by integrating birth-death population models with structurally constrained substitution models

  • Ferreiro Garcia, David
  • González Vázquez, Luis Daniel
  • Prado Comesaña, Ana María
  • Arenas Busto, Miguel
Evolutionary studies in population genetics and ecology were mainly focused on predicting and understanding past evolutionary events. Recently, however, a growing trend explores the prediction of evolutionary trajectories toward the future promoted by its wide variety of applications. In this context, we introduce a forecasting protein evolution method that integrates birth-death population models with substitution models that consider selection on protein folding stability. In contrast to traditional population genetics methods that usually make the unrealistic assumption of simulating molecular evolution separately from the evolutionary history, the present method combines both processes to simultaneously model forward-in-time birth-death evolutionary trajectories and protein evolution under structurally constrained substitution models that outperformed traditional empirical substitution models. We implemented the method into a freely available computer framework. We evaluated the accuracy of the predictions with several monitored viral proteins of broad interest. Overall, the method showed acceptable errors in predicting the folding stability of the forecasted protein variants, but, expectedly, the errors were larger in the prediction of the corresponding sequences. We conclude that forecasting protein evolution is feasible in certain evolutionary scenarios and provide suggestions to enhance its accuracy by improving the underlying models of evolution., Agencia Estatal de Investigación | Ref. PID2023-151032NB-C22, Xunta de Galicia | Ref. ED481A-2020/192
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication

  • Ortega Del Campo, Sergio
  • Fernández Ballester, Gregorio Joaquín
  • Blanes Mira, Clara
  • Guirado Osorio, Víctor
  • Díaz Martínez, Luis
  • de Ávila, Ana Isabel
  • Soria, María Eugenia
  • Martínez-González, Brenda
  • Villena González, Francisco José
  • Gómez-Maldonado, Josefa
  • Viciana Ramos, María Isabel
  • Clavijo Frutos, Encarnación
  • Santos González, Jesús L
  • Bastolla, Ugo
  • Perales, Celia
  • Domingo, Esteban
  • Viguera, Enrique
  • Fernández Escamilla, Ana María
  • Grande-Pérez, Ana
The limited durability of vaccine protection and the rapid emergence of SARS-CoV-2 variants highlight the need for antiviral strategies that extend beyond vaccination and conventional small-molecule inhibitors. Here, we explored a dual approach combining structure-guided peptides predicted to interfere with the viral replication complex with lethal mutagenesis to limit SARS-CoV-2 replication. Using the crystallographic interfaces of nsp10 with nsp14 and nsp16, we designed short inhibitory peptides predicted to interact with the viral proofreading and RNA-capping machinery. In parallel, the mutagenic analog 5-fluorouracil was evaluated to determine its effect on SARS-CoV-2 in Vero E6 cells. Peptides P1 and P6 exhibited potent antiviral activity with minimal cytotoxicity, whereas 5-FU reduced specific infectivity without impairing genome replication. Combined treatment with 5-FU and peptide P1 resulted in >104-fold reduction in infectious virus, achieving near-complete loss of infectivity at non-cytotoxic concentrations. Next-generation sequencing revealed that dual treatment increased mutation frequency, altered mutant spectra, and decreased genome stability, consistent with progression toward error catastrophe. Principal component analysis confirmed that combined treatment generated mutant spectra distinct from either monotherapy. These findings are consistent with a dual antiviral strategy in which structure-guided peptides designed to interact with components of the SARS-CoV-2 replication complex act in combination with lethal mutagenesis to produce a synergistic interaction between these two complementary processes. This integrated approach suggests a potential broad-spectrum antiviral strategy with applicability to other coronaviruses., This work was funded by grant CV20-10932 (PI: AG-P) from the Junta de Andalucía, co-financed with FEDER funds, and partially funded by Fundación Bancaria Unicaja. Partial funding for open access charges was provided by the Universidad de Málaga. U.B. was supported by grant PID2023-151032NB-C2 from the Spanish Ministry of Science (MCIU), the Spanish Research Agency (AEI/10.13039/501100011033/), and FEDER, EU. Research at the CBMSO is facilitated by the Fundación Ramón Areces and supported by the Ministerio de Ciencia, Innovación y Universidades (MICIU), through grant PID2023-146622OB-I00, financed by MICIU/AEI/10.13039/501100011033 and FEDER, EU, and by the “Severo Ochoa” Program for Centres of Excellence in Research and Development (CEX2021- 001154-S). We also acknowledge project TEC-607 2024/BIO-66 (SALAINDEC-CM from Comunidad de Madrid/FEDER). S.O.D.C. acknowledges financial support from Fundación Martín Varona. A.M.F.E. acknowledges a Teaching Staff Retraining Grant (2023), Spanish Ministry of Universities, and CIBEST/2024/114 from Generalitat Valenciana. We thank Dr. Luis Enjuanes (CNB-CSIC, Spain) for providing Vero E6 cells and Dr. Francisco Sobrino (CBMSO) for providing the VFA control peptide, Peer reviewed